$CVX

HESS JOHN B sold $137.9M of CVX

HESS JOHN B sold 710,665 shares of CHEVRON CORP (CVX) at an average of $194.10 ($192.75–$195.28, $137.94M total) across 6 trades on 2026-08-03.

Original reporting
SEC EDGAR · HESS JOHN B
Published Aug 5, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CVX
Neutral
medium confidence
Mentioned
$CVX
Relevance
8/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CVXNeutralLow
01

Why it matters

The newest fact is the disclosed sale size and timing (710,665 shares, ~$137.9M) with no stated 10b5-1 plan, which may affect short-term sentiment but does not change company fundamentals in the text.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a sustained repricing without accompanying fundamentals.

03

What to watch

No 10b5-1 plan is cited, but the article also lacks context on total holdings, prior sales cadence, tax events, or whether other insiders sold around the same time.

Relevance 8/10Novelty 5/10Timing: filed 2026-08-05, transaction dated 2026-08-03

Background

This is an SEC Form 4 insider transaction disclosure for Chevron director John B. Hess.

Company-level read

Ticker impact

$CVXNeutralMedium confidence
Context

Chevron (CVX) disclosed a Form 4 showing director John B. Hess sold 710,665 shares in open-market transactions totaling about $137.9M.

Expected impact

Likely limited, short-lived sentiment impact unless follow-on selling or new fundamentals emerge.

Evidence & confidence

The filing is a primary-source insider transaction with no 10b5-1 plan stated, but insider sales are often non-informational and the article provides no accompanying operational or guidance change.

Market effects

Could slightly influence sentiment across integrated oil peers, but no sector-wide policy or commodity driver is disclosed.

No direct regional market linkage beyond US-listed CVX sentiment.

No global macro or geopolitical linkage provided; impact should be company-specific and modest.

Counterpoint

The sale may be routine liquidity or diversification, especially since the filing does not indicate distress or a fundamental trigger.

Key entities

  • Chevron Corp

    Subject of the Form 4 insider transaction disclosure.

  • Hess John B

    Director who sold 710,665 shares of CVX across six trades on 2026-08-03.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CVXMed

HSBC raises Chevron stock price target to $250 on oil sensitivity

HSBC raised its price target on Chevron (CVX) to $250 from $218, maintaining a Buy rating. The firm cited Chevron's sensitivity to oil prices and revised earnings outlook. Chevron's 2026-2028 cash flow forecasts increased by 15%, 46%, and 23%, respectively. The stock trades at a P/E ratio of 19.8 with a 3.5% dividend yield. Chevron was involved in recent asset transactions in Angola and Namibia.

$CVXMed

Sullivan: Wall Street admits it doesn't know where oil is headed. There's one stock they do agree on

JPMorgan admits uncertainty about oil market's direction due to Iran conflict, with key economic indicators crossed. Analysts highlight Chevron (CVX) as a top pick, with Goldman Sachs raising its target to $240. BP (BP) is also noted for its evolving strategy and potential. Smaller cap Crescent Energy (CRGY) is recommended by Truist with a $19 target. Refiners like Valero (VLO), Marathon Petroleum (MPC), and others are near record highs.